D. A. Putri, D. Setiawan, and M. Yamsun, “Cost-Utility Analysis Addition of Bevacizumab to Standard Chemotherapy in KRAS-mutation Colorectal Cancer”, Pharm. : j. farm. Indones., vol. 22, no. 1, pp. 6–11, Aug. 2025.